[ST elevation myocardial infarction (STEMI) in patients aged 85 and over. Invasive management versus exclusive

T Doizon1, L Orion1, J Dimet2

  • 1Service de cardiologie, CHD de Vendée, Les Oudairies, 85000 La Roche-sur-Yon, France.

Annales De Cardiologie Et D'Angeiologie
|October 21, 2015
PubMed

Insights

Invasive management for ST elevation myocardial infarction (STEMI) in elderly patients (85+) may reduce mortality without increasing complications. This study compared invasive reperfusion versus non-invasive treatment in this high-risk population.

Area of Science:

  • Cardiology
  • Geriatric Medicine
  • Interventional Cardiology

Background:

  • ST elevation myocardial infarction (STEMI) poses significant risks for elderly patients.
  • The role of invasive management, such as percutaneous coronary intervention (PCI), in this population remains debated.

Purpose of the Study:

  • To evaluate the efficacy and safety of invasive management versus non-invasive treatment for STEMI in patients aged 85 and over.
  • To compare mortality, morbidity, complications, and loss of independence between the two management strategies.

Main Methods:

  • Retrospective single-center study of 118 patients (≥85 years) with STEMI from 2008-2013.
  • Patients were divided into invasive (coronary angiogram/fibrinolysis) and non-invasive (exclusive medical treatment) groups.
  • Outcomes assessed included mortality, intrahospital complications, and loss of independence.

Main Results:

  • The non-invasive group had a higher all-cause mortality rate (45% vs. 28%, P=0.077).
  • No significant differences were observed in intrahospital complication rates or loss of independence between groups.
  • Advanced age, female gender, history of valvular disease, and delayed primary care were identified as negative prognostic factors.

Conclusions:

  • Invasive management of STEMI in elderly patients (≥85 years) appears to reduce one-year mortality.
  • This approach does not seem to increase morbidity or loss of independence compared to non-invasive treatment.
Abstract

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
321
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
460
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
465
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.7K
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
331
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
425